Bioinformatics.org
|
|
Research
|
Online databases
Online analysis tools
Online education tools
|
Development
|
![[?]](https://www.bioinformatics.org/images/icons/info.png)
|
Forums
|
News & Commentary
Jobs Forum (Career Center)
|
|
Latest announcements
|
|
November 24-26, 2023
Vellore Institute of Technology
Vellore, India
https://vit.ac.in/school-bio-sciences-technology-sbst/indian-conference-bioinformatics-2023-inbix23-0
Late-breaking abstracts end this Sunday. Join and experience the bioinformatics gala!
Five reasons to attend Inbix2023: Indian Conference on Bioinformatics 2023:
1. It is hosted by VIT, Vellore, the top 10 private universities in India taking leaps and bounds in research in the region, and organised by Bioclues.org, India's largest bioinformatics society working for Mentor-Mentee relationships.
2. Scintillating keynotes and Life Time Achievement Awardees by revered Kenta Nakai, PB Kavi Kishor, PK Gupta and Jayaraman K Valadi and 18 other speakers across all states of India, some of the excellent speakers in the areas of #bioinformatics, #proteomics #machinelearning #genetics and #functionalgenomics
3. Two panel discussions on "Millet Bioinformatics", elevator pitch and our unique video abstracts, all free for life members
4. Have you ever heard of 12-17 year old children introduced to bioinformatics and coding? Yes, you guessed it right! We have our prestigious bioinformatics for school children (BIXS) programme through #Bioclues and this time as well, children will enthrall you with their works as we take you through students projects
5. Team Bioclues #camaraderie through the three day event where we take pride in putting it and a preconference workshop on 23rd magnifies the spirit of bioinformaticshood!
Come, join us! You will be missing something, if you haven't registered yet! What's more! The deadline for Late-breaking abstract submission ends soon: https://easychair.org/cfp/Inbix2023
#research #event #india #coding #projects #bioinformatics
|
|
Chimeric antigen receptor (CAR) T cell therapy, in which a patient's own T lymphocytes are engineered to recognize and kill cancer cells, has achieved remarkable success in some hematological malignancies in preclinical and clinical trials, resulting in six FDA-approved CAR-T products currently available in the market. Once equipped with a CAR construct, T cells act as living drugs and recognize and eliminate the target tumor cells in an MHC-independent manner.
CARs are synthetic immune receptors that connect a single-chain variable fragment (scFv), derived from a monoclonal antibody to T cell signaling domains to eradicate tumor cells independent of the major histocompatibility complex (MHC).
Once equipped with a CAR, T cells, known as CAR-T cells, act as living drugs and recognize and eliminate the target tumor cells. The conventional CAR structure consists of three modular components: the ectodomain, the transmembrane domain, and the endodomain, each of which has specific components and functions and thus the potential to be optimized.
An exemplification using Tisagenlecleucel demonstrates the approach of performing sequence retrieval for each individual region, as well as searching for the overall relevant sequence through a combination of different fragments.
Continue reading: https://synapse.patsnap.com/blog/car-t-core-functional-component-sequence-retrieval-strategy
|
Empowering Researchers with Advanced End-to-End Analysis Tools for Single-Cell and Genetic Variation Studies.
BioBam, the leading bioinformatics software company, is pleased to announce OmicsBox 3.1, its latest version packed with innovative features designed to empower researchers, scientists, and bioinformaticians in their pursuit of advanced omics data analysis and interpretation.
OmicsBox has consistently led the way by providing comprehensive genomics, transcriptomics, and metagenomics data analysis tools. This release represents a significant step forward, introducing new Single-Cell analysis capabilities, strengthening Long-Read transcriptome analysis, and enhancing Genetic Variation analysis.
Dr. Stefan Götz, CEO, stated, "With the latest release, OmicsBox now offers an exceptionally flexible analysis solution for Single-Cell RNA-Seq data, addressing the unique challenges presented by this rapidly evolving field. We anticipate that these new features will build on the success of other OmicsBox modules and make Single-Cell data analysis more accessible to the broader community."
In OmicsBox 3.1, the Single-Cell Data Analysis capabilities have been enhanced to support Expression Quantification tailored for UMI-based technologies like 10x Genomics Chromium and Drop-seq. The additions now enable end-to-end analysis of sequencing reads, from quantification to in-depth analysis, including clustering, trajectory analysis, and functional interpretation.
In the Long-Read Transcriptome data analysis, OmicsBox 3.1 introduces a new read aligner, complementing well-established tools like Flair, IsoSeq, and Sqanti. This unifies all the essential tools for PacBio or ONT long-read data analysis in a single, user-friendly platform.
The Genetic Variation Module has also received updates introducing an end-to-end solution for genetic variation analysis, featuring a cutting-edge functional enrichment tool designed exclusively for genome-wide association studies (GWAS). Additionally, support for mixed ploidy and interactive Manhattan plots has been included.
About OmicsBox:
OmicsBox is a leading bioinformatics solution that offers end-to-end data analysis of genomes, transcriptomes, metagenomes, and genetic variation studies. The application is used by top private and public research institutions worldwide and allows researchers to easily process large and complex data sets, and streamline their analysis process. It is designed to be user-friendly, efficient, and with a powerful set of tools to extract biological insights from omics data.
The software is structured in different modules, each with a specific set of tools and functions designed to perform different types of analysis, such as de-novo genome assemblies, genetic variation analysis, differential expression analysis, and taxonomic classifications of microbiome data, including the functional interpretation and rich visualizations of results. The functional analysis module, which includes the popular Blast2GO annotation methodology makes OmicsBox particularly suited for non-model organism research. Over 25k scientific research citations demonstrate this. OmicsBox works out of the box on any standard PC or laptop with Windows, Linux, or Mac. You can also explore its features with a free trial, making it even more accessible for students and researchers. https://www.biobam.com/trial/
About BioBam:
BioBam is a leading bioinformatics company that provides innovative software solutions to accelerate genomics research. The company is dedicated to developing user-friendly and powerful bioinformatics tools that simplify data analysis for researchers, empowering them to focus on data interpretation and explore new insights. BioBam aims to close the technology gap between state-of-the-art bioinformatics and applied genomics research, by transforming complex data analysis into intuitive and interactive tasks that facilitate scientific advancement.
Follow BioBam on LinkedIn, Twitter, Facebook, and YouTube.
Contacts:
Stefan Götz, CEO
BioBam Bioinformatics S.L.
sgoetz[at]biobam.com
|
December 11-13, 2023
University of Oklahoma
https://iccabs.engr.uconn.edu
Advances in high-throughput technologies such as DNA sequencing and mass spectrometry are profoundly transforming life sciences, resulting in the collection of unprecedented amounts of biological and medical data. Using this data to advance our knowledge about fundamental biological processes and improve human health requires novel computational models and advanced analysis algorithms. ICCABS aims to bring together leading academic and industry researchers to discuss the latest advances in computational methods for bio and medical sciences.
TOPICS
Topics of interest include but are not limited to: Biological Big Data Analytics, Biological modeling and simulation, Biomedical image processing, Biomedical data and literature mining, Computational genetic epidemiology, Computational metabolomics, Computational proteomics, Databases and ontologies, Gene regulation, Genome analysis, analysis, Health Informatics, High-performance bio-computing, Immunoinformatics, Molecular evolution, Population genomics, Sequence analysis, Structural bioinformatics, biology and Transcriptomics.
IMPORTANT DATES
Papers submission deadline: October 7, 2023
Notification of acceptance: November 1, 2023
Final paper deadline: November 8, 2023
Early registration deadline: November 8, 2023
|
|
EXCERPT
Nearly a decade ago, Emmanuelle Charpentier and Jennifer Doudna embarked on a journey that would transform the field of science. Their groundbreaking research on the CRISPR system revolutionized gene editing and ultimately earned them the 2020 Nobel Prize in Chemistry. Watch their captivating short film, offering insights into the process of scientific discovery, collaboration, and groundbreaking experimentation.
https://www.youtube.com/watch?v=cuHD7jCY8X4
|
|
Raghava's group has announced Python packages in the field of bioinformatics. These packages can be installed by the simple command, "pip install package-name". They are free for the scientific community. I hope the public will be benefited by them.
https://pypi.org/user/raghavagps/
|
|
EXCERPT
Adeno-associated virus (AAV) is reckoned as one of the most propitious vectors for gene research and therapy. This perception is due to an amalgamation of characteristics such as its variant types, minimal immunogenicity, extensive safety considerations, the extensive range of host cells it can infect (including both dividing and non-dividing cells), its potent dissemination capabilities, and its ability to facilitate prolonged gene expression.
In the context of the Patsnap Bio Sequence Database, it's possible to extract sequences analogous to definite AAV sequences and examine new AAV data from sources accessible to the public, thereby providing a catalyst for advanced AAV research.
Source: https://synapse.patsnap.com/blog/similar-sequence-search-for-adeno-associated-virus-aav
|
Creative Biolabs, a leading biotech company specializing in customized solutions for antibody discovery and engineering, updated its highly anticipated scholarship program for 2023 in the field of life sciences.
Creative Biolabs has established itself as a prominent player in the biotechnology industry, making significant contributions to various areas of life sciences, like antibodies, ADC development, and immunotherapies. The company has built a reputation as a trusted partner for academic researchers, pharmaceutical companies, and biotech startups, offering high-quality services and customized solutions.
Creative Biolabs Scholarship Program:
The Creative Biolabs scholarship program is set to support undergraduate and graduate students studying life sciences who demonstrate academic excellence and a strong passion for advancing the field. By inspiring students to contribute to cutting-edge research projects, the program seeks to foster scientific progress.
Eligibility Criteria:
The eligibility criteria are fair and reasonable, ensuring that deserving students receive the scholarship award. The minimum GPA requirement of 3.0 ensures that only students with above-average academic performance are considered. Additionally, extracurricular activities, leadership skills, and community involvement are taken into consideration, ensuring a comprehensive selection process.
Scholarship Details:
Selected applicants will be awarded a scholarship of $1,000, which can be utilized for tuition fees or educational expenses related to their studies in the sciences. Creative Biolabs will review all applications and select the most deserving candidate to receive the scholarship.
Application Process:
To apply for the Creative Biolabs Scholarship Program, students must complete an application form and submit it along with their academic transcripts, a reference letter from a teacher, school counselor, or community leader, and either a written essay of 800-1,000 words or a PowerPoint presentation of 10-12 pages with detailed lecture notes. The essay or PowerPoint submission should be original, grammatically correct, and emphasize the applicant's passion for their field of study, achievements, and future plans. The essay or PowerPoint requirement also allows the selection committee to evaluate the student's writing and presentation skills, which are essential qualities in their chosen field. All applications and supporting documents should be sent online to the designated email address.
All applications must be submitted by September 30, 2023, and winners will be announced in October 2023.
More details about the scholarship program can be found at https://www.creative-biolabs.com.
About Us:
Creative Biolabs is a cutting-edge biotech company that has emerged as a global leader in the field of antibody discovery and development. With a strong commitment to innovation and scientific excellence, Creative Biolabs has revolutionized the way antibodies are engineered and utilized in various research and therapeutic applications. At the core of Creative Biolabs' expertise lies their extensive premade antibody libraries, which serve as invaluable resources, providing researchers with an extensive repertoire of antibody candidates for targeted applications such as drug discovery, diagnostics, and immunotherapy.
Source: https://www.creative-biolabs.com/scholarship-program.html
|
|
November 24-26, 2023
Vellore Institute of Technology, Vellore, India
https://vit.ac.in/school-bio-sciences-technology-sbst/indian-conference-bioinformatics-2023-inbix23-0
We take immense pride in announcing that this year's Inbix'23 would be held at VIT, Vellore campus, India, with Kenta Nakai, PhD., Professor, University of Tokyo, giving a keynote.
We also take great honour in conferring Lifetime Achievement awards to PK Gupta, PhD., Professor Emeritus, CCSU, Meerut.; Jayaraman K Valadi, PhD., Distinguished Professor, FLAME University, Pune; and PB Kavi Kishor, Professor Emeritus, Osmania University, Hyderabad.
We have 24 elite talks, bioinformatics for school children talks, posters, elevator pitches and social gatherings.
CfP: https://easychair.org/cfp/Inbix2023
IMPORTANT DATES
Submissions open: August 15, 2023
Early bird registration deadline: September 15, 2023
Abstract registration deadline: October 15, 2023
Submission deadline: October 29, 2023
Best,
Prash for Bioclues and #Inbix2023 Program Committee
|
November 15-18, 2023
Phoenix, AZ, USA
https://abrcms.org
For over 20 years, the Annual Biomedical Research Conference for Minoritized Scientists (ABRCMS) – recipient of the 2019 AIMBE Excellence in STEM Education Award – has been the go-to conference for historically excluded community college, undergraduate and postbaccalaureate students in science, technology, engineering and mathematics. This year, ABRCMS is offering several options for submitting an oral abstract, poster abstract, or ePoster abstract. Gather your latest research and get ready to present your science to esteemed and established researchers from universities across the country. We welcome submissions from all students, regardless of their educational backgrounds or paths. We are actively seeking abstracts from:
- Community College Students
- Undergraduate Students (Sophomore, Junior, or Senior)
- Postbaccalaureate Students
- Master's Level Graduate Students
- Doctoral-Level Graduate Students
Abstract submissions are due September 8, 2023, at 11:59 p.m. PT.
Learn more about submitting an abstract: https://abrcms.org/index.php/present-at-abrcms/submit-an-abstract
About ABRCMS: https://abrcms.org/index.php/about-abrcms/about-abrcms
Questions? Contact abrcms[at]asmusa.org
|
|
|
|
Acknowledgments |
We wish to thank the following for their support:
|
|